The International Pharmaceutical Federation (FIP) has published an updated guide to help pharmacists prepare and respond to Ebola virus disease outbreaks and other public health emergencies.
What the guide covers
The FIP Ebola reference guide, released in 27 October, is written for pharmacists in community, hospital, primary care and public health emergency settings.
It complements the World Health Organisation’s guidance on filovirus diseases and builds on FIP’s earlier Ebola advice, published after the 2014–2016 West African outbreak.
The update reflects changes in understanding of Ebola virus species, clinical management, vaccination, infection prevention and control, surveillance and community engagement.
It also draws on lessons from recent outbreaks, including the 2026 outbreak in the Democratic Republic of Congo.
An appendix shows how the guidance can be adapted to a national context, drawing on recommendations from the National Council of FIP’s Member Organisation, the Order of Pharmacists of the Democratic Republic of the Congo, during the external review of the guidance.
The pharmacist’s role
The guide sets out practical recommendations on prevention, early recognition and referral, infection control, medicines and vaccine management, public education, surveillance and workforce preparedness.
FIP notes that these responsibilities will vary with practice settings, national legislation and the local outbreak context.
“Pharmacists are often among the most accessible healthcare professionals and can play an important role before, during and after an Ebola outbreak,” says FIP CEO Dr Catherine Duggan.
“Preparedness is not only about clinical response; it is also about ensuring that pharmacists and pharmacy teams are equipped to recognise potential cases, provide accurate information, support infection prevention and control, facilitate timely referral and maintain access to essential medicines and health services.”









